Lotus Eye Hospital & Institute Ltd
Incorporated in 1990, Lotus Eye Hospital
and Institute Ltd provides ophthalmology and other related services.[1]
- Market Cap ₹ 124 Cr.
- Current Price ₹ 59.6
- High / Low ₹ 111 / 44.1
- Stock P/E 35.0
- Book Value ₹ 28.2
- Dividend Yield 0.84 %
- ROCE 10.2 %
- ROE 7.27 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 42.2%
Cons
- Promoter holding has decreased over last quarter: -15.2%
- The company has delivered a poor sales growth of 4.35% over past five years.
- Company has a low return on equity of 5.31% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
26.23 | 29.11 | 28.69 | 29.90 | 31.13 | 33.96 | 38.02 | 38.43 | 40.55 | 32.35 | 38.90 | 47.03 | 48.50 | |
24.64 | 25.51 | 25.40 | 27.72 | 27.14 | 30.63 | 33.68 | 35.21 | 36.57 | 28.73 | 32.98 | 39.35 | 41.33 | |
Operating Profit | 1.59 | 3.60 | 3.29 | 2.18 | 3.99 | 3.33 | 4.34 | 3.22 | 3.98 | 3.62 | 5.92 | 7.68 | 7.17 |
OPM % | 6.06% | 12.37% | 11.47% | 7.29% | 12.82% | 9.81% | 11.42% | 8.38% | 9.82% | 11.19% | 15.22% | 16.33% | 14.78% |
0.36 | 0.64 | 0.39 | 0.46 | 0.58 | 0.68 | 0.91 | 0.68 | 0.21 | 0.84 | 0.88 | 1.15 | 1.27 | |
Interest | 0.05 | 0.05 | 0.04 | 0.10 | 0.16 | 0.15 | 0.18 | 0.21 | 0.24 | 0.14 | 0.21 | 0.20 | 0.09 |
Depreciation | 4.14 | 3.73 | 3.54 | 4.76 | 4.44 | 3.44 | 3.37 | 3.06 | 2.50 | 2.33 | 2.50 | 2.98 | 3.38 |
Profit before tax | -2.24 | 0.46 | 0.10 | -2.22 | -0.03 | 0.42 | 1.70 | 0.63 | 1.45 | 1.99 | 4.09 | 5.65 | 4.97 |
Tax % | -0.45% | 8.70% | 60.00% | 10.81% | 400.00% | -7.14% | -2.35% | -12.70% | 26.90% | 21.11% | 27.14% | 27.79% | |
-2.25 | 0.42 | 0.04 | -1.98 | 0.10 | 0.44 | 1.75 | 0.71 | 1.06 | 1.57 | 2.98 | 4.08 | 3.54 | |
EPS in Rs | -1.08 | 0.20 | 0.02 | -0.95 | 0.05 | 0.21 | 0.84 | 0.34 | 0.51 | 0.75 | 1.43 | 1.96 | 1.70 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 236.36% | 59.43% | 0.00% | 0.00% | 66.24% | 34.90% | 25.49% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 4% |
3 Years: | 5% |
TTM: | 4% |
Compounded Profit Growth | |
---|---|
10 Years: | 26% |
5 Years: | 19% |
3 Years: | 41% |
TTM: | -11% |
Stock Price CAGR | |
---|---|
10 Years: | 25% |
5 Years: | 24% |
3 Years: | 11% |
1 Year: | -5% |
Return on Equity | |
---|---|
10 Years: | 2% |
5 Years: | 4% |
3 Years: | 5% |
Last Year: | 7% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 |
Reserves | 30.11 | 30.53 | 30.57 | 28.59 | 28.69 | 29.26 | 29.84 | 29.32 | 30.46 | 31.90 | 33.81 | 36.78 | 37.95 |
0.43 | 0.26 | 0.18 | 0.83 | 0.66 | 0.48 | 0.29 | 0.22 | 0.32 | 0.40 | 1.24 | 0.67 | 0.00 | |
4.72 | 5.31 | 7.01 | 6.20 | 4.68 | 4.40 | 7.28 | 6.18 | 6.53 | 6.12 | 5.75 | 4.93 | 8.06 | |
Total Liabilities | 56.06 | 56.90 | 58.56 | 56.42 | 54.83 | 54.94 | 58.21 | 56.52 | 58.11 | 59.22 | 61.60 | 63.18 | 66.81 |
47.78 | 45.31 | 46.94 | 47.04 | 43.57 | 41.32 | 42.52 | 44.14 | 42.67 | 40.54 | 44.07 | 44.18 | 46.99 | |
CWIP | 0.00 | 0.18 | 0.36 | 0.27 | 0.42 | 0.65 | 0.29 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
8.28 | 11.41 | 11.26 | 9.11 | 10.84 | 12.97 | 15.40 | 12.09 | 15.44 | 18.68 | 17.53 | 19.00 | 19.82 | |
Total Assets | 56.06 | 56.90 | 58.56 | 56.42 | 54.83 | 54.94 | 58.21 | 56.52 | 58.11 | 59.22 | 61.60 | 63.18 | 66.81 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2.28 | 3.71 | 4.41 | 2.37 | 3.38 | 2.97 | 5.78 | 4.20 | 4.97 | 2.73 | 4.41 | 4.39 | |
-3.29 | -1.20 | -5.05 | -4.65 | -0.85 | -1.06 | -3.86 | -4.01 | -0.68 | 0.49 | -3.94 | -2.19 | |
0.15 | -0.16 | -0.77 | 1.87 | -0.58 | -0.25 | -1.51 | -1.41 | 0.13 | -0.32 | -1.58 | -1.71 | |
Net Cash Flow | -0.86 | 2.35 | -1.41 | -0.40 | 1.96 | 1.66 | 0.41 | -1.22 | 4.42 | 2.90 | -1.10 | 0.49 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 5.29 | 3.89 | 4.96 | 4.27 | 5.98 | 7.31 | 10.94 | 7.22 | 5.94 | 8.35 | 5.82 | 9.08 |
Inventory Days | 94.51 | 135.42 | 166.70 | 121.54 | 113.25 | 60.22 | 79.23 | 128.20 | 124.42 | 138.82 | 150.03 | 153.60 |
Days Payable | 150.77 | 160.79 | 130.52 | 125.08 | 105.51 | 87.32 | 129.95 | 167.37 | 170.41 | 220.72 | 231.21 | 173.42 |
Cash Conversion Cycle | -50.97 | -21.48 | 41.14 | 0.73 | 13.72 | -19.79 | -39.78 | -31.95 | -40.05 | -73.54 | -75.37 | -10.74 |
Working Capital Days | -9.88 | 0.25 | -13.10 | -19.90 | -8.56 | -8.92 | -26.02 | -14.53 | -21.33 | -20.99 | -10.98 | 12.34 |
ROCE % | -4.46% | 0.99% | 0.27% | -4.23% | 0.24% | 1.19% | 3.63% | 1.66% | 4.67% | 3.92% | 7.91% | 10.25% |
Documents
Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 20 Apr
-
Certificate Under Regulation 40(9) Of SEBI LODR 2015
16 Apr - Certificate issued by a practicing company secretary under Regulation 40(9) of SEBI LODR 2015
-
Compliance Certificate Under Regulation 7(3) Of SEBI LODR 2015
6 Apr - Compliance certificate signed by compliance officer of the company and RTA for the year ended 31.03.2024
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5 Apr
- Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 4 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
LEHIL is a listed Corporate Eye Hospital providing value-added super specialty services from its 8 Centers in Tamil Nadu and Kerala